Recent Finacing
Recent Raise
Phosphate Therapeutics is a UK specialty pharmaceutical company developing mineral-derived hospital drugs; its PT20 phosphate binder is in Phase 2 for hyperphosphataemia in late-stage renal disease, rights acquired from MRC.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor